GR3030614T3 - INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS - Google Patents

INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS

Info

Publication number
GR3030614T3
GR3030614T3 GR990401699T GR990401699T GR3030614T3 GR 3030614 T3 GR3030614 T3 GR 3030614T3 GR 990401699 T GR990401699 T GR 990401699T GR 990401699 T GR990401699 T GR 990401699T GR 3030614 T3 GR3030614 T3 GR 3030614T3
Authority
GR
Greece
Prior art keywords
administration
drug delivery
delivery devices
intravaginal drug
oestradiol precursors
Prior art date
Application number
GR990401699T
Other languages
English (en)
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of GR3030614T3 publication Critical patent/GR3030614T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
GR990401699T 1994-12-19 1999-06-29 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS GR3030614T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05
PCT/IE1995/000063 WO1996019196A1 (en) 1994-12-19 1995-12-19 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS

Publications (1)

Publication Number Publication Date
GR3030614T3 true GR3030614T3 (en) 1999-10-29

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
GR990401699T GR3030614T3 (en) 1994-12-19 1999-06-29 INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS

Country Status (19)

Country Link
US (1) US5855906A (el)
EP (1) EP0799025B1 (el)
JP (1) JPH10510825A (el)
CN (1) CN1138526C (el)
AR (1) AR002010A1 (el)
AT (1) ATE178204T1 (el)
AU (1) AU692659B2 (el)
CA (1) CA2207622C (el)
DE (1) DE69508791T2 (el)
DK (1) DK0799025T3 (el)
ES (1) ES2133841T3 (el)
FI (1) FI119414B (el)
GR (1) GR3030614T3 (el)
IL (1) IL116433A (el)
NO (1) NO316707B1 (el)
NZ (1) NZ298490A (el)
PE (1) PE62796A1 (el)
TR (1) TR199501599A2 (el)
WO (1) WO1996019196A1 (el)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6416780B1 (en) 1997-05-07 2002-07-09 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
DE602004026173D1 (de) * 2003-04-29 2010-05-06 Gen Hospital Corp Verfahren und vorrichtungen für die verzögerte freisetzung von mehreren arzneimitteln
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
EP1853272A1 (en) * 2005-02-03 2007-11-14 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
US20060185678A1 (en) * 2005-02-03 2006-08-24 Bronnenkant Lance J Devices for delivering agents to a vaginal tract
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
JP5137841B2 (ja) * 2005-10-13 2013-02-06 シンセス ゲーエムベーハー 薬物含浸容器
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
AU2007274081B2 (en) * 2006-07-12 2012-08-02 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
EP2170276B1 (en) * 2007-06-26 2018-08-22 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
US9586035B2 (en) 2007-12-11 2017-03-07 Massachusetts Institute Of Technology Implantable drug delivery device and methods for treatment of the bladder and other body vesicles or lumens
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
EP2437684B1 (en) 2009-06-03 2022-06-15 ForSight Vision5, Inc. Anterior segment drug delivery
CN102470237A (zh) 2009-06-26 2012-05-23 塔里斯生物医药公司 用于可植入药物递送装置的固体药物片剂
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
US9114111B2 (en) 2011-01-10 2015-08-25 Allergan, Inc. Methods for sustained treatment of bladder pain and irritative voiding
AU2012211960B2 (en) 2011-02-04 2016-12-01 Taris Biomedical Llc Implantable device for controlled release of low solubility drug
JP5989780B2 (ja) 2011-09-14 2016-09-07 フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． 眼挿入装置および方法
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
RU2652063C2 (ru) 2012-10-26 2018-04-24 Форсайт Вижн5, Инк. Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
PT2968880T (pt) 2013-03-15 2025-07-07 Taris Biomedical Llc Dispositivos de aplicação de fármaco com componente permeável a fármaco
CN105555328B (zh) 2013-06-21 2019-01-11 德普伊新特斯产品公司 膜及制造方法
CN113413393B (zh) 2013-08-19 2025-03-04 塔里斯生物医药公司 多单元药物递送装置和方法
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
HUE068689T2 (hu) * 2014-04-01 2025-01-28 Poly Med Inc Fogamzásgátló és azzal kapcsolatos eszköz
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
KR102658706B1 (ko) 2015-04-23 2024-04-17 타리스 바이오메디컬 엘엘씨 약물-투과성 성분을 구비한 약물 전달 장치 및 방법
CN114573654B (zh) * 2020-12-01 2025-09-12 北京奇明达企业管理有限公司 17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
NO316707B1 (no) 2004-04-13
EP0799025A1 (en) 1997-10-08
CN1138526C (zh) 2004-02-18
FI972579A0 (fi) 1997-06-17
ATE178204T1 (de) 1999-04-15
IL116433A (en) 2002-02-10
WO1996019196A1 (en) 1996-06-27
CA2207622C (en) 2006-10-17
NZ298490A (en) 1999-11-29
DK0799025T3 (da) 1999-10-18
JPH10510825A (ja) 1998-10-20
IL116433A0 (en) 1996-03-31
NO972798D0 (no) 1997-06-17
CN1170353A (zh) 1998-01-14
EP0799025B1 (en) 1999-03-31
NO972798L (no) 1997-08-19
US5855906A (en) 1999-01-05
FI972579L (fi) 1997-06-17
AU4399196A (en) 1996-07-10
DE69508791D1 (de) 1999-05-06
CA2207622A1 (en) 1996-06-27
ES2133841T3 (es) 1999-09-16
FI119414B (fi) 2008-11-14
TR199501599A2 (tr) 1996-07-21
PE62796A1 (es) 1996-12-28
DE69508791T2 (de) 1999-12-02
AR002010A1 (es) 1998-01-07
AU692659B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
GR3030614T3 (en) INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17-g(b)-OESTRADIOL PRECURSORS
GB2303064B (en) Medicament for nasal administration
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
GB9522403D0 (en) Intravaginal drug delivery device
AU8538991A (en) Delivery device for atomized medicaments
AU5652098A (en) A device for the administration of a liquid medicament suspension
AU1529397A (en) Delivery system for localized administration of medicaments to the upper respiratory tract
GB9016789D0 (en) Medicament administering devices
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
GB9601969D0 (en) A system for the delivery of drugs and therapeutic agents
HUP9900886A3 (en) Use of bisphosphonates preventing bone loss associated with immunosuppressive therapy for the preparation of pharmaceutical compositions
GB9418064D0 (en) Medicament administration inhaler
AU8677791A (en) Drug delivery devices
GB2305606B (en) Drug delivery composition for the nasal administration of ICAM-1
ZA975168B (en) Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments
EP0476711A3 (en) Use of 5-fluorouracil for the treatment of AIDS
ZA9510787B (en) Intravaginal drug delivery devices for the administration of 17 beta-oestradiol precursors
AU1797592A (en) Vaginal drug delivery device
ZA984832B (en) Pharmaceutical form for the administration of paclitaxel process for the preparation of a ready-to-use paclitaxel composition and use of this composition
AU3961693A (en) Compositions and devices for the intrauterine administration of drugs
GB9522402D0 (en) Intravaginal drug delivery device
AU4292993A (en) Improved delivery formulation for lipophilic drugs
SI0808158T1 (en) Medicament form for the delivery of active substances to wounds
GB9320906D0 (en) Medicament administration inhaler
GB9724777D0 (en) Intravaginal drug delivery device